SPAEN Advocacy in Action Award for best projects in sarcoma patients advocacy
Patient advocacy ensures that people are heard, take action and ultimately improve situations, achieve changes or help to fulfil unmet medical needs. We believe it is time to shout out about how important patient advocacy in sarcomas is - for patients, caregivers, healthcare professionals or anyone interested in sarcomas. We want to celebrate and honour outstanding practices, projects, initiatives or campaigns and the creators working behind these activities.
We therefore invite you to participate in the “SPAEN Advocacy in Action Award 2017”!
The winning projects/teams will receive
- 1st 2.000 €
- 2nd 1.500 €
- 3rd 1.000 €
A jury of 10 representatives – patient advocates, healthcare professionals and industry representatives – will evaluate the submissions and will select the winners.
We are looking for projects, initiatives, campaigns fulfilling the following eligibility criteria:
|Participants:||All SPAEN member groups|
|Type of projects:||
Should be sarcoma specific (Soft Tissue, Bone, GIST, Desmoid, Chordoma)
Deadline for submission: Now extended to December 15, 2017
Award Ceremony: During the 8th SPAEN Annual Conference, February 3 - 4, 2018, Milano, Italy
Every application will be recognised with a Certificate of Nomination. The best 6 submissions will be shortlisted and the winners announced at the 8th SPAEN Annual Conference 2018 in Milano, Italy.
Success may come in many shapes, sizes and stories. Recognizing this, we have merely set up some guidelines in order to make projects comparable. Please be mindful when you are making your nomination to provide clear examples of success and avoid general statements.
Relevant for the assessment of projects:
- Impact on or for patients, caregivers and community (regionally, nationally, internationally)
- Patients reached
- Potential of adaption / reproducibility by other PAGs
- Cost / Funding
- Grade of innovation
Please note: Not all criteria have to be fulfilled!
We are very much looking forward to receiving your applications and hearing about your successes in advocacy, because: “Together we can make a difference for those affected by sarcomas”.